Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Blog
Oct 4, 2018
| Rachel Schwartz
Prescription for Hope: AAM Members and Direct Relief
Press Release
Oct 1, 2018
| Rachel Schwartz
AAM Opposes Barriers to Generic Drug and Biosimilar Access in Proposed US-Mexico-Canada Agreement (USMCA)
Infographic
Sep 26, 2018
| Erica Klinger
Preserve Patient Access in NAFTA 2.0
Press Release
Sep 24, 2018
| Rachel Schwartz
Dana Mariani Joins AAM as Director, Policy
Blog
Sep 21, 2018
| Michael Brzica
$13.4 Billion a Year! Brand “Shenanigans” Are Costing Patients More Than Ever
Infographic
Sep 21, 2018
| Erica Klinger
Lost Prescription Drug Savings in the U.S.
Press Release
Sep 20, 2018
| Rachel Schwartz
AAM Statement on CBO CREATES Score
Blog
Sep 20, 2018
| Erica Klinger
Generic Prescriptions Save Lives… and Money, Too
Video
Sep 19, 2018
| Erica Klinger
Generic Drugs Are the Prescription for Savings. Don't Take Them for Granted.
Blog
Sep 19, 2018
| Erica Klinger
10 Takeaways from the Savings Report
Infographic
Sep 17, 2018
| Erica Klinger
Generic Drugs Are the Prescription for Savings. Here’s Why You Shouldn’t Take Them for Granted.
Fact Sheet
Sep 17, 2018
| Erica Klinger
How a Renegotiated NAFTA Could Keep Drug Prices High for Patients
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action